Impact of Δ<sup>9</sup>-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice. [PDF]
Slivicki RA +7 more
europepmc +1 more source
The Endoterpenoid System: A Membrane-Based Logic Framework for Integrating Cannabinoid, Olfactory, and Lipid-Sensitive Receptor Crosstalk. [PDF]
Yarar E +4 more
europepmc +1 more source
Endocannabinoid Modulation in Headache: Mechanisms, Models, and Translational Therapies. [PDF]
Wen J, Zhang Y.
europepmc +1 more source
Receptor-Selective Modulation of Cannabinoid Signaling by Cardamonin: Integrating Molecular Dynamics, Free Energy Calculations, and Behavioral Validation. [PDF]
Khalid MH +7 more
europepmc +1 more source
Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]
Bedillion MF +5 more
europepmc +1 more source
The Therapeutic Paradox of Endocannabinoid Immunomodulation: Molecular Mechanisms and Strategic Frameworks. [PDF]
Love CR.
europepmc +1 more source
Sublingual Administration for Pain Control: Pharmacology, Clinical Applications and Future Directions. [PDF]
Koushik SS +9 more
europepmc +1 more source
Related searches:
Aminopyrazine CB1 Receptor Inverse Agonists
Bioorganic and Medicinal Chemistry Letters, 2008A series of 5,6-diaryl-2-amino-pyrazines were prepared and found to have antagonist-like properties at the CB1 receptor. Subsequent SAR studies optimized both receptor potency and drug-like properties including solubility and Cytochrome-P450 inhibition potential.
James E Krause, Bertrand L Chenard
exaly +3 more sources
Lead Optimization of 5,6-Diarylpyridines as CB1 Receptor Inverse Agonists
Bioorganic and Medicinal Chemistry Letters, 2007Optimization of the biological activity for 5,6-diarylpyridines as CB1 receptor inverse agonists is described. Food intake and pharmacokinetic evaluation of 3f and 15c indicate that these compounds are effective orally active modulators of CB1.
Lex H T van der Ploeg +2 more
exaly +3 more sources
Synthesis and Activity of 4,5-Diarylimidazoles as Human CB1 Receptor Inverse Agonists
Bioorganic and Medicinal Chemistry Letters, 2005Structure-activity relationship studies directed toward the optimization of 4,5-diarylimidazole-2-carboxamide analogs as human CB1 receptor inverse agonists resulted in the discovery of the two amide derivatives 24a and b (hCB1 IC50 = 6.1 and 4.0 nM) which also demonstrated efficacy in overnight feeding studies in the rat for reduction in both food ...
Christopher W Plummer +2 more
exaly +3 more sources

